Exploring the Role of Cerebrospinal Fluid As Analyte in Neurologic Disorders

References

• NilssonC , StahlbergF , ThomsenC , HenriksenO , HerningM , OwmanC. Circadian variation in human cerebrospinal fluid production measured by magnetic resonance imaging. Am. J. Physiol.262(1 Pt 2), R20–24 (1992).
   PubMedGoogle Scholar
• DamkierHH , BrownPD , PraetoriusJ. Cerebrospinal fluid secretion by the choroid plexus. Physiol. Rev.93(4), 1847–1892 (2013).
   PubMed Web of Science ®Google Scholar
• SakkaL , CollG , ChazalJ. Anatomy and physiology of cerebrospinal fluid. Eur Ann Otorhinolaryngol Head Neck Dis.128(6), 309–316 (2011).
   PubMed Web of Science ®Google Scholar
• ShapeyJ , TomaA , SaeedSR. Physiology of cerebrospinal fluid circulation. Curr Opin Otolaryngol Head Neck Surg.27(5), 326–333 (2019).
   PubMed Web of Science ®Google Scholar
• ShahT , LeurgansSE , MehtaRIet al.Arachnoid granulations are lymphatic conduits that communicate with bone marrow and dura-arachnoid stroma. J. Exp. Med.220(2), 1–14 (2023).
   Web of Science ®Google Scholar
• TumaniH , HussA , BachhuberF. The cerebrospinal fluid and barriers - anatomic and physiologic considerations. Handb Clin Neurol.146, 21–32 (2017).
   PubMedGoogle Scholar
• HayaishiO. Molecular mechanisms of sleep-wake regulation: a role of prostaglandin D2. Philos Trans R Soc Lond B Biol Sci.355(1394), 275–280 (2000).
   PubMed Web of Science ®Google Scholar
• DavsonH , SegalMB. Physiology of the CSF and Blood–Brain Barriers (1st Edition).CRC-press, FL, USA (1996).
   Google Scholar
• MihoratTH. The third circulation revisited. J. Neurosurg.42, 628–645 (1975).
   PubMed Web of Science ®Google Scholar
• LeinonenV , VanninenR , RauramaaT. Cerebrospinal fluid circulation and hydrocephalus. Handb Clin Neurol.145, 39–50 (2017).
   PubMedGoogle Scholar
• DeisenhammerF , EggR , GiovannoniGet al.EFNS guidelines on disease-specific CSF investigations. Eur J Neurol.16(6), 760–770 (2009).
   PubMed Web of Science ®Google Scholar
• MattoxAK , YanH , BettegowdaC. The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors. Neuro Oncol.21(12), 1509–1518 (2019).
   PubMed Web of Science ®Google Scholar
• ZetterbergH , SkillbackT , MattssonNet al.Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression. JAMA Neurol.73(1), 60–67 (2016).
   PubMed Web of Science ®Google Scholar
• WellingtonH , PatersonRW , PorteliusEet al.Increased CSF neurogranin concentration is specific to Alzheimer disease. Neurology86(9), 829–835 (2016).
   PubMed Web of Science ®Google Scholar
• ZhangH , YuanF , QiY , LiuB , ChenQ. Circulating Tumor Cells for Glioma. Front Oncol.11, 607150 (2021).
   PubMed Web of Science ®Google Scholar
• SindeevaOA , VerkhovskiiRA , SarimollaogluMet al.New Frontiers in Diagnosis and Therapy of Circulating Tumor Markers in Cerebrospinal Fluid In Vitro and In Vivo. Cells.8(10), 1–15 (2019).
   Web of Science ®Google Scholar
• MagbanuaMJ , MeliskoM , RoyRet al.Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis. Cancer Res.73(23), 7134–7143 (2013).
   PubMed Web of Science ®Google Scholar
• MagbanuaMJ , RoyR , SosaEVet al.Genome-wide copy number analysis of cerebrospinal fluid tumor cells and their corresponding archival primary tumors. Genom Data.2, 60–62 (2014).
   PubMedGoogle Scholar
• SakhareAR , BarisanoG , PaJ. Assessing test-retest reliability of phase contrast MRI for measuring cerebrospinal fluid and cerebral blood flow dynamics. Magn. Reson. Med.82(2), 658–670 (2019).
   PubMed Web of Science ®Google Scholar
• NedosekinDA , JuratliMA , SarimollaogluMet al.Photoacoustic and photothermal detection of circulating tumor cells, bacteria and nanoparticles in cerebrospinal fluid in vivo and ex vivo. J Biophotonics.6(6–7), 523–533 (2013).
   PubMed Web of Science ®Google Scholar
• ChenXQ , StrounM , MagnenatJLet al.Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med.2(9), 1033–1035 (1996).
   PubMed Web of Science ®Google Scholar
• LoYM , CorbettaN , ChamberlainPFet al.Presence of fetal DNA in maternal plasma and serum. Lancet350(9076), 485–487 (1997).
   PubMed Web of Science ®Google Scholar
• AlberryM , MaddocksD , JonesMet al.Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn.27(5), 415–418 (2007).
   PubMed Web of Science ®Google Scholar
• StrounM , LyauteyJ , LederreyC , Olson-SandA , AnkerP. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin. Chim. Acta313(1–2), 139–142 (2001).
   PubMed Web of Science ®Google Scholar
• SchwarzenbachH , HoonDS , PantelK. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer.11(6), 426–437 (2011).
   PubMed Web of Science ®Google Scholar
• OrozcoAF , LewisDE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A.77(6), 502–514 (2010).
   PubMed Web of Science ®Google Scholar
• O'DriscollL , KennyE , MehtaJPet al.Feasibility and relevance of global expression profiling of gene transcripts in serum from breast cancer patients using whole genome microarrays and quantitative RT-PCR. Cancer Genomics Proteomics.5(2), 94–104 (2008).
   PubMedGoogle Scholar
• BehlingF , SchittenhelmJ. Oncogenic BRAF Alterations and Their Role in Brain Tumors. Cancers (Basel).11, 1–16 (2019).
   Web of Science ®Google Scholar
• ChenX , BaY , MaLet al.Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res.18(10), 997–1006 (2008).
   PubMed Web of Science ®Google Scholar
• CogswellJP , WardJ , TaylorIAet al.Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis.14(1), 27–41 (2008).
   PubMed Web of Science ®Google Scholar
• NassD , RosenwaldS , MeiriEet al.MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol.19(3), 375–383 (2009).
   PubMed Web of Science ®Google Scholar
• TeplyukNM , MollenhauerB , GabrielyGet al.MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol.14(6), 689–700 (2012).
   PubMed Web of Science ®Google Scholar
• LukiwWJ , AlexandrovPN , ZhaoY , HillJM , BhattacharjeeS. Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA. Neuroreport23(10), 621–626 (2012).
   PubMed Web of Science ®Google Scholar
• WangRY , GehrkeCW , EhrlichM. Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues. Nucleic Acids Res.8(20), 4777–4790 (1980).
   PubMed Web of Science ®Google Scholar
• HermanJG , GraffJR , MyohanenS , NelkinBD , BaylinSB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A.93(18), 9821–9826 (1996).
   PubMed Web of Science ®Google Scholar
• AndersenAD , BlaabjergM , BinzerMet al.Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia. J. Neurochem.141(4), 614–625 (2017).
   PubMed Web of Science ®Google Scholar
• MaX , HaoJ , WuJ , LiY , CaiX , ZhengY. Prussian Blue Nanozyme as a Pyroptosis Inhibitor Alleviates Neurodegeneration. Adv Mater.34(15), e2106723 (2022).
   PubMed Web of Science ®Google Scholar
• CarrerasN , ArnaezJ , VallsA , AgutT , SierraC , Garcia-AlixA. CSF neopterin and beta-2-microglobulin as inflammation biomarkers in newborns with hypoxic-ischemic encephalopathy. Pediatr. Res. 11794, 1–16 (2022).
   Google Scholar
• vander Velpen V , TeavT , Gallart-AyalaHet al.Systemic and central nervous system metabolic alterations in Alzheimer's disease. Alzheimers Res Ther.11(1), 93 (2019).
   PubMed Web of Science ®Google Scholar
• DittrichT , MarschS , EgliAet al.Predictors of infectious meningitis or encephalitis: the yield of cerebrospinal fluid in a cross-sectional study. BMC Infect Dis.20(1), 304 (2020).
   PubMed Web of Science ®Google Scholar
• GengH , TsangM , SubbarajLet al.Tumor metabolism and neurocognition in CNS lymphoma. Neuro Oncol.23(10), 1668–1679 (2021).
   PubMed Web of Science ®Google Scholar
• FelgenhauerK. The Filtration Concept of the Blood-CSF-Barrier as Basis for the Differentiation of CSF Proteins. In: New Concepts of a Blood–Brain Barrier (internet).Springer, MA, USA, 209–217 (1995).
   Google Scholar
• Grundke-IqbalI , IqbalK , TungYC , QuinlanM , WisniewskiHM , BinderLI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A.83(13), 4913–4917 (1986).
   PubMed Web of Science ®Google Scholar
• MastersCL , SimmsG , WeinmanNA , MulthaupG , McDonaldBL , BeyreutherK. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A.82(12), 4245–4249 (1985).
   PubMed Web of Science ®Google Scholar
• OlssonB , LautnerR , AndreassonUet al.CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. Lancet Neurol.15(7), 673–684 (2016).
   PubMed Web of Science ®Google Scholar
• BlennowK. Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx.1(2), 213–225 (2004).
   PubMedGoogle Scholar
• LewczukP , EsselmannH , OttoMet al.Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau. Neurobiol. Aging25(3), 273–281 (2004).
   PubMed Web of Science ®Google Scholar
• HockC , KonietzkoU , StrefferJRet al.Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron.38(4), 547–554 (2003).
   PubMed Web of Science ®Google Scholar
• WuJ , LiL. Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications. J Biomed Res.30(5), 361–372 (2016).
   PubMedGoogle Scholar
• de LauLM , BretelerMM. Epidemiology of Parkinson's disease. Lancet Neurol.5(6), 525–535 (2006).
   PubMed Web of Science ®Google Scholar
• JankovicJ. Parkinson's disease and movement disorders: moving forward. Lancet Neurol.7(1), 9–11 (2008).
   PubMed Web of Science ®Google Scholar
• HongZ , ShiM , ChungKAet al.DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain133(Pt 3), 713–726 (2010).
   PubMed Web of Science ®Google Scholar
• MollenhauerB , LocascioJJ , Schulz-SchaefferW , Sixel-DoringF , TrenkwalderC , SchlossmacherMG. alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol.10(3), 230–240 (2011).
   PubMed Web of Science ®Google Scholar
• van SteenovenI , MajbourNK , VaikathNNet al.alpha-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies. Mov. Disord.33(11), 1724–1733 (2018).
   PubMed Web of Science ®Google Scholar
• WennstromM , SurovaY , HallSet al.Low CSF levels of both alpha-synuclein and the alpha-synuclein cleaving enzyme neurosin in patients with synucleinopathy. PLOS ONE.8(1), e53250 (2013).
   PubMed Web of Science ®Google Scholar
• van DijkKD , BidinostiM , WeissA , RaijmakersP , BerendseHW , vande Berg WD. Reduced alpha-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity. Eur J Neurol.21(3), 388–394 (2014).
   PubMed Web of Science ®Google Scholar
• ZubelzuM , Morera-HerrerasT , IrastorzaG , Gomez-EstebanJC , Murueta-GoyenaA. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord.99, 107–115 (2022).
   PubMedGoogle Scholar
• ChangCW , YangSY , YangCC , ChangCW , WuYR. Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease. Front Neurol.10, 1388 (2019).
   PubMed Web of Science ®Google Scholar
• LiuC , CholertonB , ShiMet al.CSF tau and tau/Abeta42 predict cognitive decline in Parkinson's disease. Parkinsonism Relat Disord.21(3), 271–276 (2015).
   PubMed Web of Science ®Google Scholar
• BrownRHJr , Al-ChalabiA. Amyotrophic Lateral Sclerosis. N. Engl. J. Med.377(16), 1602 (2017).
   PubMed Web of Science ®Google Scholar
• RybergH , BowserR. Protein biomarkers for amyotrophic lateral sclerosis. Expert Rev Proteomics.5(2), 249–262 (2008).
   PubMed Web of Science ®Google Scholar
• TurnerMR , KiernanMC , LeighPN , TalbotK. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol.8(1), 94–109 (2009).
   PubMed Web of Science ®Google Scholar
• GanesalingamJ , AnJ , ShawCE , ShawG , LacomisD , BowserR. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J. Neurochem.117(3), 528–537 (2011).
   PubMed Web of Science ®Google Scholar
• TortelliR , RuggieriM , CorteseRet al.Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression. Eur J Neurol.19(12), 1561–1567 (2012).
   PubMed Web of Science ®Google Scholar
• BoylanKB , GlassJD , CrookJEet al.Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry84(4), 467–472 (2013).
   PubMed Web of Science ®Google Scholar
• GanesalingamJ , AnJ , BowserR , AndersenPM , ShawCE. pNfH is a promising biomarker for ALS. Amyotroph Lateral Scler Frontotemporal Degener.14(2), 146–149 (2013).
   PubMed Web of Science ®Google Scholar
• LehnertS , CostaJ , de CarvalhoMet al.Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener.15(5–6), 344–350 (2014).
   PubMed Web of Science ®Google Scholar
• OecklP , JardelC , SalachasFet al.Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotroph Lateral Scler Frontotemporal Degener.17(5–6), 404–413 (2016).
   PubMed Web of Science ®Google Scholar
• KeizmanD , RogowskiO , BerlinerSet al.Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis. Acta Neurol. Scand.119(6), 383–389 (2009).
   PubMed Web of Science ®Google Scholar
• MitchellRM , FreemanWM , RandazzoWTet al.A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology72(1), 14–19 (2009).
   PubMed Web of Science ®Google Scholar
• RobelinL , GonzalezDe Aguilar JL. Blood biomarkers for amyotrophic lateral sclerosis: myth or reality?Biomed Res Int.2014, 525097 (2014).
   PubMed Web of Science ®Google Scholar
• BlascoH , CorciaP , PradatPFet al.Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry. J Proteome Res.12(8), 3746–3754 (2013).
   PubMed Web of Science ®Google Scholar
• KumarA , BalaL , KalitaJet al.Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis. Clin. Chim. Acta411(7–8), 563–567 (2010).
   PubMed Web of Science ®Google Scholar
• LawtonKA , BrownMV , AlexanderDet al.Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics. Amyotroph Lateral Scler Frontotemporal Degener.15(5–6), 362–370 (2014).
   PubMed Web of Science ®Google Scholar
• MillerKD , OrtizAP , PinheiroPSet al.Cancer statistics for the US Hispanic/Latino population, 2021. CA Cancer J. Clin.71(6), 466–487 (2021).
   PubMed Web of Science ®Google Scholar
• HaberDA , GrayNS , BaselgaJ. The evolving war on cancer. Cell145(1), 19–24 (2011).
   PubMed Web of Science ®Google Scholar
• OmuroA , DeAngelisLM. Glioblastoma and other malignant gliomas: a clinical review. JAMA310(17), 1842–1850 (2013).
   PubMed Web of Science ®Google Scholar
• GrewalJ , SariaMG , KesariS. Novel approaches to treating leptomeningeal metastases. J. Neurooncol.106(2), 225–234 (2012).
   PubMed Web of Science ®Google Scholar
• GlantzMJ , ColeBF , GlantzLKet al.Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer82(4), 733–739 (1998).
   PubMed Web of Science ®Google Scholar
• GrossmanSA , KrabakMJ. Leptomeningeal carcinomatosis. Cancer Treat. Rev.25(2), 103–119 (1999).
   PubMed Web of Science ®Google Scholar
• PatelAS , AllenJE , DickerDTet al.Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases. Oncotarget.2(10), 752–760 (2011).
   PubMed Web of Science ®Google Scholar
• SottorivaA , SpiteriI , PiccirilloSGet al.Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad. Sci U S A.110(10), 4009–4014 (2013).
   PubMed Web of Science ®Google Scholar
• WestonCL , GlantzMJ , ConnorJR. Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. Fluids Barriers CNS.8(1), 14 (2011).
   PubMedGoogle Scholar
• SareenH , GarrettC , LynchDet al.The Role of Liquid Biopsies in Detecting Molecular Tumor Biomarkers in Brain Cancer Patients. Cancers (Basel).12(7), 1–16 (2020).
   Web of Science ®Google Scholar
• BallesterLY , GlitzaOliva IC , DouseDYet al.Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease. J. Neuropathol. Exp. Neurol.77(7), 628–635 (2018).
   PubMed Web of Science ®Google Scholar
• PentsovaEI , ShahRH , TangJet al.Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid. J. Clin. Oncol.34(20), 2404–2415 (2016).
   PubMed Web of Science ®Google Scholar
• WangY , SpringerS , ZhangMet al.Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord. Proc Natl Acad Sci U S A.112(31), 9704–9709 (2015).
   PubMed Web of Science ®Google Scholar
• PanW , GuW , NagpalS , GephartMH , QuakeSR. Brain tumor mutations detected in cerebral spinal fluid. Clin. Chem.61(3), 514–522 (2015).
   PubMed Web of Science ®Google Scholar
• ConnollyID , LiY , PanWet al.A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma. J. Neurooncol.135(1), 29–36 (2017).
   PubMed Web of Science ®Google Scholar
• DeMattos-Arruda L. Liquid biopsy for HER2-positive breast cancer brain metastasis: the role of the cerebrospinal fluid. ESMO Open.2(4), e000270 (2017).
   PubMed Web of Science ®Google Scholar
• DeMattos-Arruda L , MayorR , NgCKYet al.Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun.6, 8839 (2015).
   PubMed Web of Science ®Google Scholar
• Hiemcke-JiwaLS , MinnemaMC , Radersma-vanLoon JHet al.The use of droplet digital PCR in liquid biopsies: a highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid. Hematol. Oncol.36(2), 429–435 (2018).
   PubMed Web of Science ®Google Scholar
• LiY , PanW , ConnollyIDet al.Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases. J. Neurooncol.128(1), 93–100 (2016).
   PubMed Web of Science ®Google Scholar
• RhodesCH , HonsingerC , SorensonGD. Detection of tumor-derived DNA in cerebrospinal fluid. J. Neuropathol. Exp. Neurol.53(4), 364–368 (1994).
   PubMed Web of Science ®Google Scholar
• SwinkelsDW , de KokJB , HanselaarA , LamersK , BoermanRH. Early detection of leptomeningeal metastasis by PCR examination of tumor-derived K-ras DNA in cerebrospinal fluid. Clin. Chem.46(1), 132–133 (2000).
   PubMed Web of Science ®Google Scholar
• ZorofchianS , LuG , ZhuJJet al.Detection of the MYD88 p.L265P Mutation in the CSF of a Patient With Secondary Central Nervous System Lymphoma. Front Oncol.8, 382 (2018).
   PubMed Web of Science ®Google Scholar
• RhodesCH , HonsingerC , SorensonGD. PCR-detection of tumor-derived p53 DNA in cerebrospinal fluid. Am. J. Clin. Pathol.103(4), 404–408 (1995).
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature455(7216), 1061–1068 (2008).
   PubMed Web of Science ®Google Scholar
• VerheulC , KleijnA , LamfersMLM. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system. Handb Clin Neurol.146, 139–169 (2017).
   PubMedGoogle Scholar
• BaraniskinA , KuhnhennJ , SchlegelUet al.Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Blood117(11), 3140–3146 (2011).
   PubMed Web of Science ®Google Scholar
• GiladS , MeiriE , YogevYet al.Serum microRNAs are promising novel biomarkers. PLOS ONE.3(9), e3148 (2008).
   PubMed Web of Science ®Google Scholar
• LawrieCH , GalS , DunlopHMet al.Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol.141(5), 672–675 (2008).
   PubMed Web of Science ®Google Scholar
• SkogJ , WurdingerT , van RijnSet al.Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol.10(12), 1470–1476 (2008).
   PubMed Web of Science ®Google Scholar
• ValadiH , EkstromK , BossiosA , SjostrandM , LeeJJ , LotvallJO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol.9(6), 654–659 (2007).
   PubMed Web of Science ®Google Scholar
• WeberJA , BaxterDH , ZhangSet al.The microRNA spectrum in 12 body fluids. Clin. Chem.56(11), 1733–1741 (2010).
   PubMed Web of Science ®Google Scholar